Sorafenib Inhibits STAT3 Activation to Enhance TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells

Shengbing Huang(Zhengzhou University), Frank A. Sinicrope(Mayo Clinic in Arizona)
Molecular Cancer Therapeutics
March 1, 2010
Cited by 93


Related Papers